Patients with breast cancer prescribed capecitabine, an oral chemotherapy with a complex, cyclical regimen, were randomly assigned to enhanced usual care (EUC) or PRO arm. Participants were asked to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback